Harbor Health Care ETF (MEDI)

Built on a rich history of Health Care Investing

Harbor Health Care ETF (MEDI)

Built on a rich history of Health Care Investing

Welcome
Overview
Performance
Holdings
Investment Team
Documents
chevron

Request a Call


Locate Your Harbor Consultant
INSTITUTIONAL INVESTORS ONLY: Please enter your zip code to locate an Investment Consultant.

Why Invest in MEDI?

Health care costs have increased over time, while forecasts signal continued upward trend looking ahead. A broader shift towards value-based approaches within health care is likely needed, with emphasis on lower costs of care and improved patient outcomes. This may enable opportunities for health care companies best positioned to facilitate transition towards value over quantity.

In addition, health care is home to other disruptive themes such as targeted oncology, liquid biopsy, gene therapy, orphan diseases, and others that may represent compelling long-term growth opportunities.

The investment team behind MEDI seeks to construct a portfolio capable of benefiting from the secular growth and innovation of the U.S. health care system, while achieving alpha relative to the broader Health Care sector by investing in quality businesses with differentiated products, technologies, and services which meet the team's disciplined valuation criteria.

Matthew R. Renna
Partner, Portfolio Manager, Westfield Capital Management Company L.P.

"Health care is a sector that we are very passionate about, and one in which we have a strong history."

Read the Q&A for a timely look at the Health Care sector.



Resources

Access in-depth fund information and insights to help you capitalize on potential opportunities related to health care investing.


Overview

Investment Team
Westfield Capital Management

Current Price

As of 1/5/2024

$24.82

Price (NAV)

$0.05

NAV Daily Change ($)

0.20%

NAV Daily Change (%)

0.12%

NAV YTD Return

$24.84

Market Price

$0.07

Market Daily Change ($)

0.28%

Market Daily Change (%)

0.16%

Market YTD Return

Fund Facts

As of 1/5/2024

11/16/2022

Inception Date

0.80

Expense Ratio (%)
disclaimer

$6.206

Total Net Assets (million)

250,000

Shares Outstanding
(As of 1/8/2024)

MEDI

Ticker

41151J869

Cusip

NYSE

Exchange

US41151J896

ISIN

Foreside Fund Services, LLC

Distributor
disclaimer

Annually

Dividend Frequency

Health

Morningstar Category

Russell 3000® Growth Health Care Index

Benchmark

5,086,341

Implied Liquidity™ (Shares)
disclaimer

$125,988,605.53

Implied Liquidity
disclaimer

Investment Objective:

The Fund seeks long-term growth of capital.

Pricing/Trading

As of 1/5/2024

$24.83

Bid/Ask Mid Price

$24.84

Closing Market Price

$0.00

Premium/Discount ($)

0.01%

Premium/Discount (%)

 

2023

Q1 2024

YTD

Days Traded at a Premium21344
Days Traded at a Discount3700

0.32%

30-Day Median Bid/Ask Spread

21,680

Exchange Volume (Shares)

USD

Trading Currency

Historical Premium Discount to NAV

No Data Available

Performance

Total Returns

Quarter-End

3 Mo.

YTD Return

1 Yr.

Since Fund Inception

Net Expense Ratio

Gross Expense Ratio

Health Care ETF - at NAV
14.36%
24.81%
24.81%
23.82%
0.80%disclaimer
0.80%
Market Price
14.51%
24.86%
24.86%
24.59%
--
--
Russell 3000 Growth Health Care Index
9.28%
11.67%
11.67%
12.16%
--
--

Performance data shown represents past performance and is no guarantee of future results. Past performance is net of management fees and expenses and reflects reinvested dividends and distributions. Past performance reflects the beneficial effect of any expense waivers or reimbursements, without which returns would have been lower. Investment returns and principal value will fluctuate and when redeemed may be worth more or less than their original cost. Returns for periods less than one year are not annualized. Current performance may be higher or lower and is available through the most recent month end at harborcapital.com or by calling 800-422-1050.

The Russell 3000® Growth Health Care Index is an unmanaged index generally representative of companies involved in medical services or health care in the Russell 3000 Index, which is comprised of the 3,000 largest U.S. companies as determined by total market capitalization. This unmanaged index does not reflect fees and expenses and is not available for direct investment.

Chart

Ex-Date

Record Date

Payable Date

Ordinary Income

Short Term Capital Gains

Long Term Capital Gains

Total Distribution

12/21/2023
12/22/2023
12/27/2023
0.16429
0.29701
--
0.46130
12/21/2022
12/22/2022
12/27/2022
--
--
--
0.00000

Holdings

Portfolio Characteristics

As of 11/30/2023

161284.5

Wtd Avg Market Cap ($Mil)

6.05

Price/Book Ratio

39

Adjusted Trailing P/E Ratio

6.8

% EPS Growth - Past 3 Yr

11.75

Return on Equity (%)

22.2

Forecasted P/E Ratio

Top Ten Holdings

As of 1/8/2024

Company Name [Ticker]

% of Net Assets

UNITEDHEALTH GROUP INC[UNH]
15.6
ASCENDIS PHARMA A/S - ADR[ASND]
12.3
ELI LILLY & CO[LLY]
9.6
ABBVIE INC[ABBV]
8.7
DEXCOM INC[DXCM]
4.6
LEGEND BIOTECH CORP-ADR[LEGN]
3.6
ICON PLC[ICLR]
3.5
OPTION CARE HEALTH INC[OPCH]
3.4
ROCKET PHARMACEUTICALS INC[RCKT]
3.1
HUMANA INC[HUM]
2.9
% of Total Holdings:
67.3%

This information should not be considered as a recommendation to purchase or sell a particular security. The weightings, holdings, industry, sector and/or countries mentioned may change at any time and may not represent current or future investments.

As of 1/8/2024

Company Name [Ticker]

Category Name

Country

Cusip

Shares

Current Price ($)

Market Value ($)

% of Net Assets

UNITEDHEALTH GROUP INC [UNH]
EQUITY
91324P102
1,799
537.38
966,746.62
15.6
ASCENDIS PHARMA A/S - ADR [ASND]
EQUITY
04351P101
5,863
129.72
760,548.36
12.3
ELI LILLY & CO [LLY]
EQUITY
532457108
961
618.55
594,426.55
9.6
ABBVIE INC [ABBV]
EQUITY
00287Y109
3,316
162.14
537,656.24
8.7
DEXCOM INC [DXCM]
EQUITY
252131107
2,287
123.98
283,542.26
4.6
LEGEND BIOTECH CORP-ADR [LEGN]
EQUITY
52490G102
4,009
56.44
226,267.96
3.6
ICON PLC [ICLR]
EQUITY
G4705A100
800
270.72
216,576.00
3.5
OPTION CARE HEALTH INC [OPCH]
EQUITY
68404L201
6,519
32.60
212,519.40
3.4
ROCKET PHARMACEUTICALS INC [RCKT]
EQUITY
77313F106
6,860
28.26
193,863.60
3.1
HUMANA INC [HUM]
EQUITY
444859102
389
458.27
178,267.03
2.9
INSULET CORP [PODD]
EQUITY
45784P101
719
197.87
142,268.53
2.3
BOSTON SCIENTIFIC CORP [BSX]
EQUITY
101137107
2,397
58.16
139,409.52
2.2
MASIMO CORP [MASI]
EQUITY
574795100
1,113
111.62
124,233.06
2.0
LANTHEUS HOLDINGS INC [LNTH]
EQUITY
516544103
1,918
64.49
123,691.82
2.0
VAXCYTE INC [PCVX]
EQUITY
92243G108
1,892
59.79
113,122.68
1.8
GE HEALTHCARE TECHNOLOGY [GEHC]
EQUITY
36266G107
1,292
76.62
98,993.04
1.6
COOPER COS INC/THE [COO]
EQUITY
216648402
268
365.93
98,069.24
1.6
AVANTOR INC [AVTR]
EQUITY
05352A100
4,320
21.79
94,132.80
1.5
ALKERMES PLC [ALKS]
EQUITY
G01767105
3,248
28.56
92,762.88
1.5
CYMABAY THERAPEUTICS INC [CBAY]
EQUITY
23257D103
3,279
23.02
75,482.58
1.2
IDEXX LABORATORIES INC [IDXX]
EQUITY
45168D104
131
537.36
70,394.16
1.1
CENCORA INC [COR]
EQUITY
03073E105
332
211.36
70,171.52
1.1
HAEMONETICS CORP/MASS [HAE]
EQUITY
405024100
847
81.43
68,971.21
1.1
NEUROCRINE BIOSCIENCES INC [NBIX]
EQUITY
64125C109
511
132.48
67,697.28
1.1
MOONLAKE IMMUNOTHERAPEUTICS [MLTX]
EQUITY
61559X104
1,238
54.68
67,693.84
1.1
INNOVIVA INC [INVA]
EQUITY
45781M101
3,871
16.58
64,181.18
1.0
BIOGEN INC [BIIB]
EQUITY
09062X103
248
257.88
63,954.24
1.0
MURAL ONCOLOGY PLC [MURA]
EQUITY
G63365103
11,134
5.74
63,909.16
1.0
BICYCLE THERAPEUTICS PLC-ADR [BCYC]
EQUITY
088786108
2,992
17.08
51,103.36
0.8
REPLIGEN CORP [RGEN]
EQUITY
759916109
281
171.63
48,228.03
0.8
89BIO INC [ETNB]
EQUITY
282559103
3,260
11.53
37,587.80
0.6
SHOCKWAVE MEDICAL INC [SWAV]
EQUITY
82489T104
178
200.25
35,644.50
0.6
XENON PHARMACEUTICALS INC [XENE]
EQUITY
98420N105
769
45.50
34,989.50
0.6
INSPIRE MEDICAL SYSTEMS INC [INSP]
EQUITY
457730109
197
175.65
34,603.05
0.6
IRHYTHM TECHNOLOGIES INC [IRTC]
EQUITY
450056106
273
102.093
27,871.42
0.4
Total
--
--
--
--
--
6,080
97.9
Cash and Other Assets Less Liabilities
--
--
--
--
--
--
2.1
Total Net Assets
--
--
--
--
--
--
100%

As of 9/30/2023

Health Care ETF (MEDI)

Russell 3000 Growth Health Care Index

-

Health Care

MEDI: 98.0%

Benchmark: 99.9%

-

Consumer Discretionary

MEDI: NaN%

Benchmark: 0.0%

-

Consumer Staples

MEDI: NaN%

Benchmark: NaN%

-

Industrials

MEDI: NaN%

Benchmark: 0.0%

-

Materials

MEDI: NaN%

Benchmark: 0.0%

MEDI: Health Care ETF

Benchmark: Russell 3000 Growth Health Care Index

As of 11/30/2023

Economic Sector

Health Care ETF %

Russell 3000 Growth Health Care Index %

Health Care

Economic sector icon
0.4
0.2

Industrials

Economic sector icon
0.0
-15.9

Consumer Discretionary

Economic sector icon
0.0
-13.3

Information Technology

Economic sector icon
0.0
0.6

Materials

Economic sector icon
0.0
-44.9

Investment Team


Westfield Capital Management

Westfield Capital Management Company, L.P. is dedicated to providing strong and consistent investment performance based on a disciplined, team-based approach, with exceptional client service. Westfield believes their greatest strength comes from the collective wisdom of a fully engaged and inspired team working together with clear objectives. Additionally, Westfield embraces their partnership structure, which aligns the advancement of the organization with their clients and serves to attract and retain exceptional talent.

Documents

Name

Date

File

Important Information

Investing involves risk, principal loss is possible. Unlike mutual funds, ETFs may trade at a premium or discount to their net asset value. Harbor ETFs are new and have limited operating history to judge.

Shares are bought and sold at market price not net asset value (NAV). Market price returns are based upon the closing composite market price and do not represent the returns you would receive if you traded shares at other times.

There is no guarantee that the investment objective of the Fund will be achieved.  Stock markets are volatile and equity values can decline significantly in response to adverse issuer, political, regulatory, market and economic conditions. Since the Fund may hold foreign securities, it may be subject to greater risks than funds invested only in the U.S. These risks are more severe for securities of issuers in emerging market regions. Foreign currencies can decline in value and can adversely affect the dollar value of the fund. Since the Fund typically invests in a limited number of companies, an adverse event affecting a particular company may hurt the Fund's performance more than if it had invested in a larger number of companies. Health Care Industry Risk: Because the Fund seeks to invest all, or substantially all, of its assets in the health care industry, the value of its shares will depend on the general condition of the that industry. The health care industry may be affected by any number of factors, including, but not limited to, lapsing patent protection, industry innovation, extensive government regulation, restrictions on government reimbursement for medical expenses, research and development costs, limited product lines, product liability litigation, an increased emphasis on outpatient services, and competitive forces. Authorized Participant Concentration/Trading Risk: Only authorized participants ("APs") may engage in creation or redemption transactions directly with the Fund. The Fund is classified as non-diversified, a non-diversified Fund may invest a greater percentage of its assets in securities of a single issuer, and/or invest in a relatively small number of issuers, it is more susceptible to risks associated with a single economic, political or regulatory occurrence than a more diversified portfolio. New Fund Risk: There can be no assurance that the Fund will grow to or maintain an economically viable size, in which case the Board of Trustees may determine to liquidate the Fund. Small and Mid Cap Risk: The Fund's performance may be more volatile because it may invest in issuers that are smaller companies.

The views expressed herein may not be reflective of current opinions, are subject to change without prior notice, and should not be considered investment advice.

Weighted Average Market Capitalization: The average size of the companies in a portfolio or index as measured by the market value of outstanding shares.

Price/Book: The price-to-book (P/B) ratio evaluates a firm's market value relative to its book value.

Adjusted Trailing P/E Ratio: The Adjusted Trailing P/E (Price/Earnings) Ratio is the closing stock price divided by the sum of the last 12 months actual EPS.

% EPS Growth – Past 3 year: Earnings per share refers to the bottom-line measure of a company’s profitability defined as net income divided by the number of outstanding shares.

Return on Equity: Return on equity (ROE) is a measure of financial performance calculated by dividing net income by shareholders' equity.

Forecasted P/E Ratio: a measure of the P/E (price-to-earnings) ratio using forecasted earnings for the P/E calculation.

Bid/Ask Mid Price: the midpoint between the highest bid and the lowest offer, as of the time that the Fund’s NAV is calculated, typically 4 p.m. Eastern Time.

Premium/Discount ($): the difference between the Fund’s market price and NAV, expressed as a percentage of NAV. A premium is the amount that the Fund is trading above the reported NAV. A discount is the amount that the Fund is trading below the reported NAV.

30-Day Median Bid/Ask Spread: calculated by identifying national best bid and national best offer ("NBBO") for each fund as of the end of each 10 second interval during each trading day of the last 30 calendar days and dividing the difference between each such bid and offer by the midpoint of the NBBO. The median of those values is identified and that value is expressed as a percentage (rounded to the nearest hundredth).

3966322  

Blue Background

Connect with us | LinkedIn Logo IconLinktree icon to podcast media links

Harbor Funds Distributors, Inc. is the Distributor of the Harbor Mutual Funds.
Foreside Fund Services, LLC is the Distributor of the Harbor ETFs.
FINRA Brokercheck logo in white color

Investing involves risk and the potential loss of capital.

Investors should carefully consider the investment objectives, risks, charges and expenses of a fund before investing. To obtain a summary prospectus or prospectus for this and other information, click here or call 800-422-1050. Read it carefully before investing.

All trademarks or product names mentioned herein are the property of their respective owners. Copyright © 2024 Harbor Capital Advisors, Inc. All rights reserved.